IDERA PHARMACEUTICALS, INC.·4

Jul 23, 4:36 PM ET

Kirby John J. 4

4 · IDERA PHARMACEUTICALS, INC. · Filed Jul 23, 2020

Insider Transaction Report

Form 4
Period: 2020-07-21
Kirby John J.
V.P. of Finance, PFO & PAO
Transactions
  • Award

    Stock Option (Right to Buy)

    2020-07-21+50,00050,000 total
    Exercise: $2.48Exp: 2030-07-21Common Stock (50,000 underlying)
Footnotes (1)
  • [F1]The stock option award was granted under the Issuer's 2013 Stock Incentive Plan. The stock option vests and becomes exercisable over a four-year period commencing on July 21, 2020. Twenty-five percent (25%) of the stock option vests and becomes exercisable on July 21, 2021 (first anniversary of the date of grant) and the balance vests in twelve equal quarterly installments over the remaining three years of the four-year period, subject to continued service with the Issuer.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -